801 LONG-TERM PROGNOSIS OF COMBINED HEPATOCELLULAR AND CHOLANGIOCARCINOMA AFTER CURATIVE RESECTION: COMPARISON WITH HEPATOCELLULAR CARCINOMA AND CHOLANGIOCARCINOMA

2009 ◽  
Vol 50 ◽  
pp. S293
Author(s):  
J.-H. Lee ◽  
W. Kim ◽  
H.Y. Kim ◽  
D. Kim ◽  
Y.J. Jung ◽  
...  
2008 ◽  
Vol 134 (4) ◽  
pp. A-823-A-824
Author(s):  
Jeong-Hoon Lee ◽  
Yoon Jun Kim ◽  
Bum Joon Park ◽  
Donghee Kim ◽  
Yong Jin Jung ◽  
...  

2008 ◽  
Vol 48 ◽  
pp. S151-S152
Author(s):  
J.H. Lee ◽  
Y.J. Kim ◽  
B.J. Park ◽  
D.H. Kim ◽  
Y.J. Jung ◽  
...  

2016 ◽  
Vol 23 (S4) ◽  
pp. 467-474 ◽  
Author(s):  
Yukiyasu Okamura ◽  
Ryo Ashida ◽  
Yusuke Yamamoto ◽  
Takaaki Ito ◽  
Teiichi Sugiura ◽  
...  

2020 ◽  
Vol 2020 ◽  
pp. 1-7
Author(s):  
Hong Zhao ◽  
Qi Wang ◽  
Changling Luo ◽  
Ligai Liu ◽  
Wen Xie

Liver-function decompensation or hepatocellular carcinoma (HCC) gradually appears after chronic hepatitis B progresses to cirrhosis. Effective antiviral treatment can significantly improve the long-term prognosis of decompensated patients, and some patients present recompensation of decompensated hepatitis B cirrhosis. At present, there are limited research data on the recompensation of decompensated hepatitis B cirrhosis. There is still controversy regarding the evaluation time, evaluation indicators, influencing factors, and long-term prognosis of recompensation.


Sign in / Sign up

Export Citation Format

Share Document